Dr. Linda J. Rever, MD

Dr. Rever practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Rever's NPI, 1891741989, was assigned on May 26, 2006. Dr. Rever graduated from University of Maryland School of Medicine - Baltimore in 1981. Dr. Rever's California license number on file is G56940.

Dr. Rever's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Rever's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Rever to 1 more other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rever practices, 3 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Rever's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Rever is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Rever's licenses on file in 6 states: California, District of Columbia, Maryland, New Jersey, West Virginia and Pennsylvania.

Dmand AI lists lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Rever treats.

CMS data shows 329 Medicare services from Dr. Rever across 9 procedure codes in 2024, for 286 Medicare patients. Medicare paid $29,362 for them.

CMS counts 286 Medicare patients who saw Dr. Rever in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rever's median patient age at 57, with 59% women.

In 2024, Dr. Rever wrote 609 Medicare Part D claims for 51 patients. 96% of them were for generic drugs. CMS names the drug for 519 of them, across 20 drugs with 11 or more claims each, at $13,176 in total drug cost. In 2023, CMS named 502 claims across 14 drugs.

Dr. Rever accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rever as offering telehealth.

Dmand AI links Dr. Rever to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Agnosia and Perceptual Disorders.

CMS Open Payments shows 32 general payments to Dr. Rever from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $478.

Dr. Rever graduated from University of Maryland School of Medicine - Baltimore in 1981.

Dr. Rever is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.